Drug Shortage Report for AURO-DAPAGLIFLOZIN / METFORMIN
Report ID | 242954 |
Drug Identification Number | 02533073 |
Brand name | AURO-DAPAGLIFLOZIN / METFORMIN |
Common or Proper name | Auro-Dapagliflozin-Metformin` |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE DAPAGLIFLOZIN |
Strength(s) | 850MG 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 60 |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-11-14 |
Estimated end date | 2025-01-28 |
Actual end date | 2025-01-28 |
Shortage status | Resolved |
Updated date | 2025-01-29 |
Company comments | Alternative pack size of 100's and 500's available for sale. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2025-01-29 | English | Compare |
v7 | 2025-01-28 | French | Compare |
v6 | 2025-01-28 | English | Compare |
v5 | 2024-11-15 | French | Compare |
v4 | 2024-11-15 | English | Compare |
v3 | 2024-11-15 | English | Compare |
v2 | 2024-11-14 | French | Compare |
v1 | 2024-11-14 | English | Compare |
Showing 1 to 8 of 8